Promethera® has built the complete supply chain for its off-the-shelf allogeneic liver cell therapy products through acquisitions and strategic partnerships. The company has established and is continuously optimizing its manufacturing set-up to meet both current and future needs, along with demand for its cell therapy products.
Fully-formed supply chain and product platform
Mastering the supply chain for an off-the-shelf allogeneic cell therapy product.
Organs unsuitable for transplantation
Cell isolation of liver progenitor cells under GMP conditions
GMP aseptic manufacturing
Cells are frozen for storage and delivery direct to the patient’s bedside
Reconstitution and application via intravenous delivery at the bedside
TREATING HUNDREDS OF PATIENTS
DONOR – 1 LIVER